Title 42, The Public Health and WelfareRelease 119-73not60
§289g–3 Breast Implant Research
Title 42 › Chapter 6A— PUBLIC HEALTH SERVICE › Subchapter III— NATIONAL RESEARCH INSTITUTES › Part H— General Provisions › § 289g–3
Summary
The NIH director can study long-term health effects of silicone breast implants, whether gel or saline. Research can create tests to measure silicone in body fluids and track implant recipients for long-term outcomes and complications. A breast implant is a device inserted to enlarge or rebuild a woman's breast.
Full Legal Text
Title 42, §289g–3
The Public Health and Welfare, Source: USLM XML via OLRC
(a)The Director of NIH may conduct or support research to examine the long-term health implications of silicone breast implants, both gel and saline filled. Such research studies may include the following:
(1)Developing and examining techniques to measure concentrations of silicone in body fluids and tissues.
(2)Surveillance of recipients of silicone breast implants, including long-term outcomes and local complications.
(b)For purposes of this section, the term “breast implant” means a breast prosthesis that is implanted to augment or reconstruct the female breast.
Legislative History
Notes & Related Subsidiaries
Statutory Notes and Related Subsidiaries
Breast Implants; Study by Comptroller General Pub. L. 107–250, title II, § 214, Oct. 26, 2002, 116 Stat. 1615, which provided that the Comptroller General was to conduct a study of information typically provided by health professionals to women on breast implant surgery and to report the findings of the study to Congress, was repealed by Pub. L. 111–8, div. G, title I, § 1301(g), Mar. 11, 2009, 123 Stat. 829.
Reference
Citations & Metadata
Citation
42 U.S.C. § 289g–3
Title 42, The Public Health and Welfare
Last Updated
Apr 5, 2026
Release point: 119-73not60